Abstract

A comprehensive analysis of sequence variation was carried out comparing the fusion (F) protein of human respiratory syncytial viruses (hRSV) from antigenic groups A and B with the prototype sequence of the A2 strain, also belonging to antigenic group A. The limited number of full bovine RSV F sequences available were included, as well as an extensive set of F sequences from the related human metapneumovirus (hMPV). The results were analysed in the context of the recently determined three dimensional F protein structures, with antigenic sites mapped to these. Although a high degree of sequence conservation in hRSV F exists, and sequence changes did not correlate with location of antigenic sites, preferential accumulation of amino acid changes in certain antigenic sites was noted. When the analysis was extended to hMPV F, a high number of changes was noticed, in agreement with the limited degree of sequence conservation. However, some conserved regions were noted, which may account for the limited number of cross-reactive monoclonal antibodies described between hRSV F and hMPV F. These results provide information about the degree of sequence and antigenic variation currently found in the F protein of circulating viruses. They highlight the importance of establishing a baseline dataset to monitor for future changes that might evolve should preventative immunological measures be made widely available.

Highlights

  • Human Respiratory Syncytial Virus is an enveloped virus of the Orthopneumovirus genus within the newly created Pneumoviridae family [1] which includes bovine RSV and pneumonia virus of mice (PVM). hRSV strains are classified into two main antigenic groups - hRSV A and hRSV B- which cause seasonal epidemics in winter months and circulate worldwide

  • Comparison of the F protein sequences from hRSV and bovine RSV (bRSV) strains and from human metapneumovirus (hMPV)

  • Testing of the probability of a mutation occurring in these regions showed a statistically significant increased odds ratio of this occurring at the signal peptide (SP) and p27, but not for the transmembrane domain (TM)

Read more

Summary

Introduction

Human Respiratory Syncytial Virus (hRSV) is an enveloped virus of the Orthopneumovirus genus within the newly created Pneumoviridae family [1] which includes bovine RSV (bRSV) and pneumonia virus of mice (PVM). hRSV strains are classified into two main antigenic groups - hRSV A and hRSV B- which cause seasonal epidemics in winter months and circulate worldwide. HRSV is an important cause of respiratory disease in the elderly and in immunocompromised adults, contributing to a substantial disease burden in these populations [5]. Despite such a high disease burden, no licensed hRSV vaccine is yet available. Almost twenty prophylactic vaccine candidates and monoclonal antibodies (mAbs) are in clinical trials, progressing from Phase I to III [7]. If, when available, they achieve widespread use, these vaccines could have a substantial effect on hRSV disease morbidity and mortality

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call